The nuclear medicine group of Siemens Medical Systems received Food and Drug Administration clearance last month for a version of its E.Cam gamma camera that uses hybrid PET/SPECT detectors made from lutetium oxyortho-silicate and sodium iodide
The nuclear medicine group of Siemens Medical Systems received Food and Drug Administration clearance last month for a version of its E.Cam gamma camera that uses hybrid PET/SPECT detectors made from lutetium oxyortho-silicate and sodium iodide (LSO/NaI). The Hoffman Estates, IL, division developed the hybrid system in collaboration with R&D partner CTI of Nashville. It featured the unit at last months Society of Nuclear Medicine conference in Toronto (SCAN Special Report June 1998). Siemens hopes the hybrid detectors will enable nuclear medicine physicians to image radioisotopes at both low and high energy ranges, making the camera equally suitable for either SPECT or PET studies.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
New Analysis Forecasts Substantial Cost Savings with the Use of Photon Counting CT for CCTA
March 8th 2025The use of ultra-high-resolution photon-counting CT in the evaluation of stable chest pain may significantly reduce follow-up tests and invasive coronary angiography (ICA) procedures, possibly resulting in millions in health-care cost savings, according to a cost-effectiveness analysis presented recently at the European Congress of Radiology.